TA Levin Large Cap Value VP
|Security Description||% of Total Net Assets|
|Bio-Rad Laboratories, Inc., Class A||5.94%|
|American International Group, Inc.||5.60%|
|JPMorgan Chase & Co.||4.81%|
|Occidental Petroleum Corp.||4.34%|
|CenterPoint Energy, Inc.||4.03%|
|General Motors Co.||3.87%|
|Bank of America Corp.||3.85%|
|DuPont de Nemours, Inc.||3.59%|
|TreeHouse Foods, Inc.||3.59%|
|Nokia OYJ, ADR||3.12%|
|Keurig Dr. Pepper, Inc.||3.09%|
|Kraft Heinz Co.||2.99%|
|Lincoln National Corp.||2.66%|
|CommScope Holding Co., Inc.||2.55%|
|Lowe's Cos., Inc.||2.48%|
|Exxon Mobil Corp.||1.97%|
|Change Healthcare, Inc.||1.72%|
|Goodyear Tire & Rubber Co.||1.09%|
|Net Other Assets (Liabilities)||1.47%|
Unlike the fund’s regulatory filings, the portfolio data and its presentation in this document are not required to conform to Generally Accepted Accounting Principles (GAAP) and Securities and Exchange Commission (SEC) presentation requirements. Therefore, it differs from that in the complete statement of investments in the annual and semiannual report to shareholders filed with the SEC on Form N-CSR, and the complete statement of investments provided in the first and third quarter SEC Form N-Q filings for each fiscal year.
Transamerica Series Trust portfolios are only available through the purchase of a variable life insurance policy or variable annuity contract.
No part of this material may be reproduced in any form, or referred to in any publication, without express written permission.